Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Michael Gnant, Martin Filipits, Richard Greil, +21

Annals of Oncology

Surgical OncologyBreast OncologyRecurrence ScoreDistant RecurrenceCancer Recurrence +8

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

Meinolf Karthaus, Albrecht Kretzschmar, H. Kröning, +12

Annals of Oncology

Venous DiseaseOncologyVenous ThrombosisCentral Venous CathetersPatient Safety +8

Randomized, double-blind, placebo-controlled, phase III study of bevacizumab with docetaxel or docetaxel with placebo as first-line therapy for patients with locally recurrent or metastatic breast cancer (mBC): AVADO.

David Miles, A. Chan, Gilles Romieu, +7

Journal of Clinical Oncology

Metastatic Breast CancerOncologyLba1011 BackgroundBreast OncologyCancer Management +13

Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study

Dusan Kotasek, G. Steger, Wylam Faught, +5

European Journal of Cancer

Hematological MalignancyDarbepoetin AlfaOncologyMedicineHematology +7

A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study

Ursula Wiedermann, C Wiltschke, Joanna Jasińska, +8

Breast Cancer Research and Treatment

Metastatic Breast CancerBreast OncologyCancer ImmunosurveillanceImmunologyTumor Immunity +6

Single-agent gemcitabine as second- and third-line treatment in metastatic breast cancer

Thomas Brodowicz, Wolfgang J. Köstler, R. Möslinger, +9

The Breast

Metastatic Breast CancerBreast OncologyMedicineSingle-agent GemcitabinePharmacology +11

Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy.

Susanne Taucher, Margaretha Rudas, Michael Gnant, +7

Endocrine Related Cancer

Biopsy TissueSurgical OncologyBreast OncologyMedicineHormonal Receptor +13

Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases

Rupert Bartsch, Anna S. Berghoff, Ursula Pluschnig, +11

British Journal of Cancer

Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF

Michael Hejna, Wolfgang J. Köstler, Markus Raderer, +5

European Journal of Cancer

InflammationAllergyMedicineOral CavityOral Medicine +7

Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment

Gernot Hudelist, Wolfgang J. Köstler, Johannes Attems, +7

British Journal of Cancer